The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

Another is to find stocks with relatively affordable price tags per share. Although it's sometimes the case that the most ...

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...

Novo Nordisk continues to deliver strong revenue, profit growth, and high economic profitability. Read why I rate NVO stock a ...

Regional equity markets closed in positive territory on Tuesday, building positive momentum after a muted trading session on ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma ...

HONG KONG (AP) — Asian shares fell Monday and U.S. futures and the dollar weakened after Moody’sRatings downgraded the ...

Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

May 16 - As Denmark's Novo Nordisk shops for its next CEO to replace ... In the face of those challenges, analysts said, Lilly has benefited from the connections its CEO David Ricks has built ...

Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster ... citing “recent market challenges” and a steep decline in the company's share price. Lars Fruergaard Jorgensen's ...